"leukemia" trang 9 - tải miễn phí từ tailieuXANH
SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia

SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia
13    69    0
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study

The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study
12    59    0
Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia

Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia
11    95    0
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens

Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens
14    67    0
Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5+/− leukemia

Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5+/− leukemia
6    76    0
LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia

LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia
20    49    0
A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells

A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells
8    58    0
DECIDER: Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapy

DECIDER: Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
8    61    0
Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells

Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells
15    46    0
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia

ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia
6    57    0
Study protocol of the RAND-study: A multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia

Study protocol of the RAND-study: A multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia
6    66    0
Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia

Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia
5    53    0
The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells

The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells
9    51    0
Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stress

Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stress
9    67    0
Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia

Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia
11    50    0
Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells

Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells
7    47    0
Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: A case cohort study

Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: A case cohort study
9    54    0
Overexpression of primary microRNA 221/222 in acute myeloid leukemia

Overexpression of primary microRNA 221/222 in acute myeloid leukemia
12    68    0
NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients

NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients
6    47    0
Patient Activation through Counseling and Exercise – Acute Leukemia (PACE-AL) – a randomized controlled trial

Patient Activation through Counseling and Exercise – Acute Leukemia (PACE-AL) – a randomized controlled trial
13    62    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.